Personalized precision medicine powered by AI for cancer therapy
Make sense of your DNA
Stage
Not given
Not given
Founded
Not given
Not given
Based in
US
FI
Pricing model
Contact for pricing
Paid
Pricing
Not given
For Individuals: starting from $11/month (one genome included, upgrade anytime). For Health Practitioners: starting from $99/month (work with up to 15 active genomes, unlimited archived genomes).
Key features
Analyzes digital pathology with no additional tissue staining required
Rapid results within 1-2 days after specimen receipt
Validated across diverse populations including African American and non-African American men
FDA De Novo authorization for prostate cancer risk stratification
Insurance coverage for Medicare and many commercial plans
Provides 5 and 10-year distant metastasis risk for breast cancer
Identifies breast cancer patients who benefit from chemotherapy
Included in NCCN Clinical Practice Guidelines for Prostate Cancer
102 prebuilt health topic panels
Medication response data with 1,165 medications covered
Functional hotspots inspection for protein regions
7 evidence signals for variant review
Organized findings by health topics
Gene-level variant review with frequency and consequence
28,139 medication-response notes
What makes it different
No additional tissue preparation needed, uses existing H&E slides
Validated across multiple large randomized phase III clinical trials
FDA De Novo clearance as Software as a Medical Device
Financial assistance program to make tests affordable regardless of income
Compare computer scores, clinical records, and variant details before drawing conclusions
ArteraAI
Gene Inspector Pro